Memorial Deadline:
No RGCS review required for the LOI
External Deadline:
Friday 8th, October 2021
Description
Through its International Research Grant Program, Alzheimer’s Association (ALZ) aims to fundinvestigations that advance our understanding of Alzheimer’s disease, help identify new treatment strategies, provide information to improve care for people with dementia, and further our knowledge of brain health and disease prevention.
As ALZ’s funding initiatives have grown and matured, grant categories have expanded to support researchers at every stage in their careers. Funded projects now explore the broadest possible spectrum of biological approaches to prevention and treatment solutions, social and behavioural strategies for improving the effects of dementia on individuals and their families and professional caregivers, clinical studies, and adaptive technologies.
Through a partnership with ALZ, Brain Canada will be funding Canadian-led teams who meet peer review recommendations.
Deadline for receipt of Letters of Intent: October 8, 2021, 5:00 PM EST
Deadline for receipt of Full Applications: November 19, 2021, 5:00 PM EST
Funding for Canadian-led teams has been made possible by matched funds contributed by the Canada Brain Research Fund, an innovative partnership between the Government of Canada (through Health Canada) and Brain Canada, and by Alzheimer’s Association, a leading health organization for accelerating global research, driving risk reduction and early detection, and maximizing quality care and support for people living with Alzheimer’s.
